All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

147

Reset

147 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CHF10196florensocatibPhase 31 trial

    Chiesi Farmaceutici S.p.A. · Bronchiectasis

  • HR-1703Phase 31 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma With Eosinophilic Phenotype

  • JKN2401Phase 31 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · Chronic Obstructive Pulmonary Disease (COPD)

  • QMF149Phase 31 trial

    Novartis · Asthma

  • QVM149Phase 31 trial

    Novartis · Asthma

  • SC1011Phase 31 trial

    Guangzhou JOYO Pharma Co., Ltd · Idiopathic Pulmonary Fibrosis

  • TEV-56248Phase 31 trial

    Teva · Asthma

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • VerekitugUPB-101Phase 24 trials

    Upstream Bio Inc. · Severe Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • ENV-294Phase 23 trials

    Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma

  • GalvokimigUCB9741Phase 23 trials

    UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis

  • KT-621Phase 23 trials

    Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)

  • VapendavirVPV, VapendaivrPhase 23 trials

    Altesa Biosciences, Inc. · Rhinovirus Infection, COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection

  • 9MW1911Phase 22 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Pulmonary Disease COPD

  • AD17002LThPhase 22 trials

    Advagene Biopharma Co. Ltd. · Eosinophilic Asthma

  • ARO-RAGEPhase 22 trials

    Arrowhead Pharmaceuticals · Asthma

  • AZD0292Phase 22 trials

    AstraZeneca · Bronchiectasis With Pseudomonas Aeruginosa Colonization

  • FB825Phase 22 trials

    Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis

  • GSK3862995BPhase 22 trials

    GSK · Bronchiectasis, Pulmonary Disease, Chronic Obstructive

  • HB0056Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

  • IfetrobanPhase 22 trials

    Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited

  • JNJ-95597528Phase 22 trials

    Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma

  • LASN01Phase 22 trials

    Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy

  • LondamocitinibAZD4604Phase 22 trials

    AstraZeneca · Asthma

  • NS-863Phase 22 trials

    NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension

  • PA9159 Metered-DosePhase 22 trials

    Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma

  • per day for 28 daysPhase 22 trials

    Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma

  • PRA-216Phase 22 trials

    Prana Therapies Inc · Chronic Obstructive Pulmonary Disease (COPD), Mild to Moderate Asthma

  • RC1416Phase 22 trials

    Nanjing RegeneCore Biotech Co., Ltd. · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe Asthma

  • SolrikitugPhase 22 trials

    Uniquity One (UNI) · Eosinophilic Esophagitis (EoE), COPD

  • TQC2938Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Seasonal Allergic Rhinitis

  • TTI-101Phase 22 trials

    Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis

  • WIN378Phase 22 trials

    Windward Bio · COPD (Chronic Obstructive Pulmonary Disease), Asthma

  • XKH001InjectionXKH001Phase 22 trials

    Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis

  • ABBV-142Phase 21 trial

    AbbVie · Idiopathic Pulmonary Fibrosis

  • AGMB-447Phase 21 trial

    Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)

  • ANG003Phase 21 trial

    Anagram Therapeutics, Inc. · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)

  • AP02Phase 21 trial

    Avalyn Pharma Inc. · Idiopathic Pulmonary Fibrosis (IPF)

  • APL-9796Phase 21 trial

    Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension

  • ARCT-032Phase 21 trial

    Arcturus Therapeutics, Inc. · Cystic Fibrosis, CFTR Gene Mutation

  • AZD6793Phase 21 trial

    AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD)

  • AZD8630Phase 21 trial

    AstraZeneca · Asthma

  • AZD8965Phase 21 trial

    AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)

  • BBT-877Phase 21 trial

    Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis

  • BC006Phase 21 trial

    Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)

  • BI 1819479Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • BI 3810477Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • BI 765423Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial

    BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)

NewerPage 2 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.